Portal hypertension after prolonged use of trastuzumab emtansine: nodular regenerative hyperplasia with autoimmune features. RSD [Internet]. 2021 Jul. 7 [cited 2025 Dec. 6];10(8):e10810817005. Available from: https://rsdjournal.org/rsd/article/view/17005